FDA product code PKB: Autosomal Recessive Carrier Screening Gene Mutation Detection System

PKB is the FDA product code for autosomal recessive carrier screening gene mutation detection system. It is a Class II device, regulated under 21 CFR 866.5940 and reviewed by the Pathology panel. Devices under PKB reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

Autosomal recessive carrier screening gene mutation detection system is a qualitative in vitro molecular diagnostic system used for genotyping of clinically relevant variants in genomic DNA isolated from human peripheral whole blood or saliva specimens intended for prescription use or over-the-counter use. The device is intended for autosomal recessive disease carrier screening in adults of reproductive age. The device is not intended for copy number variation, cytogenetic, or biochemical testing.

Classification

FieldValue
Device nameAutosomal Recessive Carrier Screening Gene Mutation Detection System
Device classClass II
Regulation21 CFR 866.5940
Review panelPA — Pathology
Medical specialtyImmunology
Premarket route510(k)

Recalls for PKB devices

FDA recall records list no recalls for product code PKB.

Frequently asked questions

What is FDA product code PKB?

PKB is the FDA product code for autosomal recessive carrier screening gene mutation detection system. It is a Class II device, regulated under 21 CFR 866.5940 and reviewed by the Pathology panel.

What device class is PKB?

Class II, regulation 21 CFR 866.5940. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times